PALISADE BIO, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PALISADE BIO, INC. (PALI) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$93.45 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-08
- PALISADE BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$5.03M.
- PALISADE BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- PALISADE BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$100.93K.
- PALISADE BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was $7.49M.
- PALISADE BIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $2.36M, a 67.48% decline from fiscal 2015.
- PALISADE BIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $7.25M.
- PALISADE BIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$15.56M.
- PALISADE BIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$537.05K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$93.45K 10-Q · filed 2017-08-08 | |||
| 2016-12-31 | -$5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | -$5.03M derived: sum of 2 quarters · filed 2017-03-23 | -$5.13M derived: sum of 3 quarters · filed 2017-08-08 | $2.36M 10-K · filed 2017-03-23 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$100.93K derived: sum of 2 quarters · filed 2017-08-08 | $7.39M 10-Q · filed 2016-11-08 | $4.84M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-06-30 | -$100.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $7.39M 10-Q · filed 2017-08-08 | $4.84M derived: sum of 3 quarters · filed 2017-08-08 | $14.83M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $7.49M 10-Q · filed 2017-05-10 | $4.94M derived: sum of 2 quarters · filed 2017-05-10 | $14.93M derived: sum of 3 quarters · filed 2017-05-10 | $14.83M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | -$2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $7.44M derived: sum of 2 quarters · filed 2017-03-23 | $7.34M derived: sum of 3 quarters · filed 2017-03-23 | $7.25M 10-K · filed 2017-03-23 |
| 2015-09-30 | $9.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $9.90M derived: sum of 2 quarters · filed 2016-11-08 | $9.80M 10-Q · filed 2016-11-08 | $9.72M derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-06-30 | -$92.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$191.20K 10-Q · filed 2016-08-11 | -$267.24K derived: sum of 3 quarters · filed 2016-08-11 | -$362.33K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | -$98.28K 10-Q · filed 2016-05-09 | -$174.32K derived: sum of 2 quarters · filed 2016-05-09 | -$269.41K derived: sum of 3 quarters · filed 2016-05-09 | -$438.95K derived: sum of 4 quarters · filed 2016-05-09 |
| 2014-12-31 | -$76.04K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$171.13K derived: sum of 2 quarters · filed 2016-03-14 | -$340.67K derived: sum of 3 quarters · filed 2016-03-14 | -$15.56M 10-K · filed 2016-03-14 |
| 2014-09-30 | -$95.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$264.63K derived: sum of 2 quarters · filed 2015-11-09 | -$15.49M 10-Q · filed 2015-11-09 | -$15.58M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | -$169.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$15.39M 10-Q · filed 2015-08-10 | -$15.49M derived: sum of 3 quarters · filed 2016-03-14 | -$15.69M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | -$15.22M 10-Q · filed 2015-05-08 | -$15.32M derived: sum of 2 quarters · filed 2016-03-14 | -$15.52M derived: sum of 3 quarters · filed 2016-03-14 | -$15.66M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | -$92.33K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$299.44K derived: sum of 2 quarters · filed 2016-03-14 | -$440.23K derived: sum of 3 quarters · filed 2016-03-14 | -$537.05K 10-K · filed 2016-03-14 |
| 2013-09-30 | -$207.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$347.90K derived: sum of 2 quarters · filed 2014-11-07 | -$444.72K 10-Q · filed 2014-11-07 | |
| 2013-06-30 | -$140.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$237.61K 10-Q · filed 2014-08-08 | ||
| 2013-03-31 | -$96.82K 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | -$254.86K 10-K · filed 2015-03-16 | |||
| 2011-12-31 | -$480.85K 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |